• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Sonography could replace biopsy in some breast tumors

Article

Ultrasound is an acceptable alternative to biopsy for the management of tumors hidden to x-ray mammography but diagnosed as probably benign under the ultrasound Breast Imaging Reporting and Data System, according to a study in the July issue of Radiology.

Ultrasound is an acceptable alternative to biopsy for the management of tumors hidden to x-ray mammography but diagnosed as probably benign under the ultrasound Breast Imaging Reporting and Data System, according to a study in the July issue of Radiology.

Investigators at the Ambulatory Care Center in Steyr, Austria, retrospectively evaluated 445 nonpalpable solid masses from 409 women who underwent ultrasound between January 2001 and December 2003. These masses were partially or completely obscured by dense breast tissue on mammography but were classified as probably benign by ultrasound. Of the 445 masses, 442 remained stable during a mean follow-up of more than three years. The false-negative rate and negative predictive value of the test were 0.2% and 99.8%, respectively.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.